Difficulty: Medium
Average Score: 79%
Practice
The drug of choice for hypoparathyroidism is
Correct answer
C
Rationale
In the treatment of hypoparathyroidism, the drug of choice is Vitamin D (Option C). This is because hypoparathyroidism is characterized by low levels of parathyroid hormone, leading to decreased calcium levels in the blood. Vitamin D helps in the absorption of calcium from the gut and its reabsorption from the kidneys, thus aiding in raising and maintaining the calcium levels in the body.
Option A, Parathormone, is the actual hormone that is deficient in hypoparathyroidism. However, due to its short half-life and the challenges associated with its administration, Vitamin D is preferred for long-term management.
Option B, Calcium lactate, is a calcium supplement that can be used to raise calcium levels in the body, but it does not address the underlying cause of hypoparathyroidism.
Option D, Pamidronate, is a bisphosphonate drug used to treat conditions of high calcium levels, such as hypercalcemia, and is not indicated for hypoparathyroidism.
In an educational context, understanding the appropriate pharmacological management of endocrine disorders like hypoparathyroidism is crucial for nurses, pharmacists, and other healthcare professionals. By knowing the mechanism of action and rationale behind the choice of Vitamin D in this scenario, healthcare providers can make informed decisions to optimize patient care and outcomes.
Option A, Parathormone, is the actual hormone that is deficient in hypoparathyroidism. However, due to its short half-life and the challenges associated with its administration, Vitamin D is preferred for long-term management.
Option B, Calcium lactate, is a calcium supplement that can be used to raise calcium levels in the body, but it does not address the underlying cause of hypoparathyroidism.
Option D, Pamidronate, is a bisphosphonate drug used to treat conditions of high calcium levels, such as hypercalcemia, and is not indicated for hypoparathyroidism.
In an educational context, understanding the appropriate pharmacological management of endocrine disorders like hypoparathyroidism is crucial for nurses, pharmacists, and other healthcare professionals. By knowing the mechanism of action and rationale behind the choice of Vitamin D in this scenario, healthcare providers can make informed decisions to optimize patient care and outcomes.